Skip to main content
This website uses cookies. By continuing to use this website you are agreeing to our use of cookies as described in our privacy policy.
Client Work

Duchesnay Inc. v. Teva Canada Limited and the Minister of Health

Fasken
Reading Time 1 minute read
Proceedings to prohibit the Minister of Health from issuing a notice of compliance which would allow the sale by Teva of a generic version of Diclectin, a combination of doxylamine succinate and pyridoxine hydrochloride used for the treatment of nausea and vomiting of pregnancy, until the expiry of Canadian patent no 2,350,195. The patent at issue covers a formulation of doxylamine and pyridoxine, together with a disintegrating agent, in a capsule covered by an enteric coating which satisfies particular dissolution profiles. The notice of allegation was withdrawn by Teva and the proceedings subsequently discontinued. Duchesnay was advised in these proceedings by a team from Fasken Martineau that included Marie Lafleur, Julie Desrosiers and Christian Leblanc. See Court file